Keith Michael Gottesdiener
Director, Intercept Pharmaceuticals.
Companies
- Septerna, Inc.Board member Sep 29, 2025 to now1
- Prime Medicine, Inc.Board member Oct 19, 2022 to now2
- Prime Medicine, Inc.Officer Oct 19, 2022 to now2
- Intercept PharmaceuticalsBoard member Jul 21, 2016 to Nov 13, 20233
- Rhythm (United states)Board member Oct 4, 2017 to Mar 11, 20204
- Rhythm (United states)Chief executive officer Oct 4, 2017 to Mar 11, 20204
- Rhythm (United states)President Oct 4, 2017 to Mar 11, 20204
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Prime Medicine, Inc. PRME3,628,578 shares5$13.1M at $3.61Oct 10, 2024
Intercept Pharmaceuticals ICPT0 shares6Nov 8, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Oct 8, 2024Gift 226,925 shares of Prime Medicine, Inc.5
- Oct 8, 2024Gift 226,925 shares of Prime Medicine, Inc.5
- Jun 5, 2024Gift 250,000 shares of Prime Medicine, Inc.7
- Jun 5, 2024Gift 250,000 shares of Prime Medicine, Inc.7
- Nov 11, 2023Gift 5,000 shares of Prime Medicine, Inc.8
- Nov 11, 2023Gift 7,500 shares of Prime Medicine, Inc.8
- Nov 8, 2023Returned to company 8,111 shares at $19.00 of Intercept Pharmaceuticals6
- Nov 8, 2023U 24,719 shares at $19.00 of Intercept Pharmaceuticals6
- May 24, 2023Granted 8,111 shares of Intercept Pharmaceuticals9
- May 25, 2022Granted 7,737 shares of Intercept Pharmaceuticals10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARSepterna, Inc., Board member
- 2SEC EDGARPrime Medicine, Inc., Board member
- 3
- 4SEC EDGARRhythm (United states), Board member
- 5
- 6
- 7SEC EDGARForm 4 filed Jun 7, 2024
- 8SEC EDGARForm 4 filed Nov 14, 2023
- 9SEC EDGARForm 4 filed May 25, 2023
- 10SEC EDGARForm 4 filed May 27, 2022